RMO No. 36-2020 sets the VAT refund process for covered imported diabetes, cholesterol, and hypertension drugs paid from Jan. 23 to Jul. 9, 2020.
Importers that paid VAT on covered prescription drugs for diabetes, high cholesterol, and hypertension during the transition period from January 23, 2020 to July 9, 2020 must file a written refund claim within two years from payment and must prove that the VAT was not used as input tax. RMO No. 36-2020 matters because it gives the working procedure for recovering erroneously paid VAT on imported medicines covered by the DOH-FDA approved list, while also requiring complete documentary support before the claim can move from BIR processing to BOC validation and payment.
What RMO No. 36-2020 Changed
RMO No. 36-2020 provides uniform policies and procedures for the processing, verification, approval, and payment of claims for refund of erroneously paid value-added tax on imported drugs prescribed for diabetes, high cholesterol, and hypertension. The covered drugs are those included in the Department of Health-Food and Drug Administration approved list, and the covered period is from the effectivity of Republic Act No. 11467 on January 23, 2020 up to July 9, 2020, the effectivity date of Revenue Regulations No. 18-2020.
The practical change is that taxpayers are given a defined filing and verification route for this specific VAT refund. Instead of treating the refund as a generic tax refund request, the order identifies where the claim should be filed, what documents must accompany the application, how the BIR will verify non-utilization of input VAT, and how the Bureau of Customs VAT Payment Certification and import documents will be validated.
The order is anchored on Section 204(C) of the Tax Code of 1997, as amended. No credit or refund of taxes or penalties is allowed unless the taxpayer files a written claim with the Commissioner within two years after payment of the tax or penalty. For businesses, this two-year period is the controlling limitation period. A taxpayer that misses the two-year filing window risks losing the refund even if the VAT was erroneously paid.
Who Is Affected
RMO No. 36-2020 primarily affects importers and taxpayer-claimants that paid VAT upon importation of drugs prescribed for diabetes, high cholesterol, and hypertension, provided those drugs are part of the DOH-FDA approved list and the VAT was paid during the January 23, 2020 to July 9, 2020 period. The affected taxpayers may include pharmaceutical importers, distributors, healthcare-related companies, and large taxpayers that imported covered medicines and paid VAT before the exemption procedure under RR No. 18-2020 became effective.
The order also affects corporate taxpayers preparing refund dockets, tax managers reconciling import VAT against VAT returns, and customs or accounting personnel tasked with securing BOC documentation. Large taxpayers must file and process their claims with the Large Taxpayers Audit Division under the Large Taxpayers Service, while non-large taxpayers must file with the Revenue District Office where the taxpayer-claimant is registered.
Key Filing Requirements and Documents
The claim must be supported by three copies of the Application for Tax Credit/Refund, BIR Form No. 1914. The claimant must also submit a copy of payment of the Annual Registration Fee for the period of claim, and for corporate claimants, the latest General Information Sheet duly received by the Securities and Exchange Commission.
The taxpayer must submit the relevant monthly VAT declaration or quarterly VAT return, duly certified by the BIR office where the claimant is registered, except for returns filed through eFPS. This requirement is critical because the BIR will compare the VAT refund claim against the taxpayer’s VAT filings to confirm that the import VAT was not already reported and claimed as input tax credit under Section 110 of the Tax Code.
The claimant must also execute a sworn statement certifying two matters: first, that the VAT paid on imported items was not reported and claimed as input tax credit in monthly VAT declarations and quarterly VAT returns for purposes of computing VAT payable; and second, that the company did not file and will not file any similar claim with another BIR office or with the Bureau of Customs. This requirement is intended to prevent double recovery and inconsistent claims.
A Delinquency Verification Certificate is also required. For non-large taxpayers, the required offices are the Collection Division of the respective region and the Accounts Receivable Monitoring Division. For large taxpayers, the required offices are the LT Collection Enforcement Division or LT Division Cebu or Davao, and the Accounts Receivable Monitoring Division.
The application must also include a notarized Secretary’s Certificate for a corporate claimant, or a Special Power of Attorney for an individual claimant, identifying the authorized representative who may file, sign documents, and follow up VAT refund claims. At least one valid government-issued ID with specimen signatures must accompany this authority document.
Two importation schedules are required. The first is the schedule of importations for the period of claim, conforming to Annex A.1, corresponding to the amount sought to be refunded. The second is the schedule of importations corresponding to the amount of input VAT claimed per monthly VAT declarations or quarterly VAT returns, conforming to Annex A.2. The second schedule is used to prove that the import VAT included in the refund claim was not utilized as input VAT.
The claimant must also submit the VAT Payment Certification issued by the BOC Revenue Accounting Division, copies of Import Entry and Internal Revenue Declarations or Single Administrative Documents, the Statement of Settlement of Duties and Taxes duly authenticated by the BOC, and copies of commercial invoices. The import and invoice documents must be arranged according to the schedules required under Annexes A.1 and A.2.
Verification, Approval, and Payment Process
The head of the processing office will issue Tax Verification Notices for the verification of VAT refund claims under the order. RMO No. 36-2020 expressly states that this process should not be treated as a regular tax audit or investigation. However, it also clarifies that the relevant investigating office may later issue an electronic Letter of Authority against the taxpayer-claimant. Businesses should therefore ensure that the refund docket is internally consistent with VAT returns, import records, and accounting books.
The assigned Revenue Officers must confirm that the imported items were not reported and claimed as input tax credit. This is done by comparing the schedule of importations for the VAT payments sought to be refunded with the schedule of importations corresponding to the input VAT claimed in the taxpayer’s monthly VAT declarations or quarterly VAT returns.
The BIR processing office must validate the VAT Payment Certification issued by the BOC Revenue Accounting Division, together with the authenticated import documents submitted by the claimant. The BOC Revenue Accounting Division must send a scanned copy of the certification through its dedicated email address to the dedicated email address of the BIR processing office, which should be indicated in the taxpayer’s request upon filing with the BOC.
Recommendations on claims are reviewed, approved, and acted upon regardless of the amount of claim. The Assessment Division or the office of the concerned Head Revenue Executive Assistant of the Large Taxpayers Service reviews the report and the docket. The Regional Director or Assistant Commissioner of the Large Taxpayers Service approves or disapproves the VAT refund recommendation and endorses a copy of the recommendation and docket to the BOC for validation and payment, or for appropriate action.
Delinquent Tax Liabilities and Other Compliance Risks
RMO No. 36-2020 does not prescribe a separate monetary penalty schedule for non-compliance with the refund procedure. The immediate risk is procedural: an incomplete or inconsistent claim may be delayed, denied, or not endorsed for BOC validation and payment. The most important substantive risk is claiming a refund for VAT that has already been used as input tax credit, because the order requires express certification and BIR verification on non-utilization.
Taxpayer-claimants with outstanding delinquent tax liabilities must settle those liabilities before the refund memorandum and attachments are endorsed to the BOC. For this purpose, the BIR requires a Certification of the Settlement of Outstanding Liabilities from the applicable Collection Division or LT Collection Enforcement Division, together with the relevant monitoring and appellate offices using the format and procedures under RMO No. 29-2014.
Practical Steps for Importers and Tax Teams
Tax teams should first isolate all importations of covered prescription drugs for diabetes, high cholesterol, and hypertension made from January 23, 2020 to July 9, 2020, and confirm that the products are included in the DOH-FDA approved list. They should then identify the VAT actually paid on importation and reconcile those payments against monthly VAT declarations and quarterly VAT returns.
The second step is to confirm that the VAT was not used as input tax. This should not be done by assumption. The accounting team should prepare a reconciliation between import entries, BOC payment documents, VAT returns, input tax schedules, and general ledger accounts. The sworn statement required under the order should be executed only after the taxpayer has completed this reconciliation.
The third step is to build the refund docket in the same order required by the BIR. BIR Form No. 1914, proof of Annual Registration Fee payment, SEC General Information Sheet, certified VAT returns or eFPS records, sworn statement, Delinquency Verification Certificate, corporate authority documents, Annex A.1 and A.2 schedules, BOC VAT Payment Certification, authenticated IEIRD or SAD, SSDT, and commercial invoices should be organized before filing. A disorganized refund docket can create avoidable follow-up requests and delay the endorsement to the BOC.
The most common search phrases for this issue are RMO No. 36-2020 VAT refund, refund of VAT on imported medicines Philippines, VAT exemption diabetes hypertension cholesterol drugs, BOC VAT Payment Certification refund, and BIR Form 1914 VAT refund importation. These terms point to the same core compliance concern: the claimant must prove that the imported medicines are covered, that VAT was paid during the covered period, and that the same VAT was not already recovered through input tax credits.
How Ablola, Saribong & Gueco Can Help
VAT refund claims involving imported medicines require more than filing a form. They require tax reconciliation, customs document review, corporate authority documents, sworn certifications, and coordination between BIR and BOC procedures. Ablola, Saribong & Gueco assists importers, pharmaceutical companies, distributors, and corporate taxpayers in preparing complete VAT refund dockets, reviewing input tax utilization, addressing delinquency verification issues, and managing BIR submissions with a view toward practical recovery and audit-readiness.
For assistance with RMO No. 36-2020, VAT refund claims, BIR Form No. 1914 filings, or tax documentation for imported medicines, contact Ablola, Saribong & Gueco through MakatiLawFirm.com.